Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Hemolysis D006461 131 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hypertension D006973 115 associated lipids
Influenza, Human D007251 11 associated lipids
Leishmaniasis D007896 19 associated lipids
Mycoses D009181 18 associated lipids
Otitis Externa D010032 8 associated lipids
Peritonitis D010538 38 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Urethritis D014526 9 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Czeizel AE et al. A population-based case-control teratological study of oral nystatin treatment during pregnancy. 2003 Scand. J. Infect. Dis. pmid:14723358
Schultheiss G et al. Activation of apical K+ conductances by muscarinic receptor stimulation in rat distal colon: fast and slow components. 2003 J. Membr. Biol. pmid:14724763
Vitale RG et al. Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media. 2003 J. Antimicrob. Chemother. pmid:12775672
Szkotak AJ et al. The role of the basolateral outwardly rectifying chloride channel in human airway epithelial anion secretion. 2003 Am. J. Respir. Cell Mol. Biol. pmid:12777250
Grassmé H et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. 2003 Nat. Med. pmid:12563314
Vanden Bossche H et al. Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects. 2003 J. Vet. Pharmacol. Ther. pmid:12603774
Preney L et al. Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp. 2003 Mycoses pmid:14641623
Silva L et al. Solution conformation of a nitrobenzoxadiazole derivative of the polyene antibiotic nystatin: a FRET study. 2003 J. Photochem. Photobiol. B, Biol. pmid:14644562
Alma MH et al. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. 2003 Biol. Pharm. Bull. pmid:14646179
Eggimann P et al. Management of Candida species infections in critically ill patients. 2003 Lancet Infect Dis pmid:14652203
Goldenberg D et al. The use of otic powder in the treatment of acute external otitis. 2002 May-Jun Am J Otolaryngol pmid:12019482
Lopez-De-Blanc SA et al. Antifungal topical therapy in oral chronic candidosis. A comparative study. 2002 Jul-Oct Med Oral pmid:12134127
Jonsbu E et al. The influence of carbon sources and morphology on nystatin production by Streptomyces noursei. 2002 J. Biotechnol. pmid:11911923
Charvalos E et al. New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum. 2002 Mycopathologia pmid:11913760
Lazrak A et al. cAMP regulation of Cl(-) and HCO(-)(3) secretion across rat fetal distal lung epithelial cells. 2002 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11880289
Zeiske W et al. Insect midgut K(+) secretion: concerted run-down of apical/basolateral transporters with extra-/intracellular acidity. 2002 J. Exp. Biol. pmid:11893760
Karpichev IV et al. Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism. 2002 J. Biol. Chem. pmid:11916977
Meletiadis J et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. 2002 Antimicrob. Agents Chemother. pmid:11751112
Shimura M et al. Circadian rhythm in intracellular Cl(-) activity of acutely dissociated neurons of suprachiasmatic nucleus. 2002 Am. J. Physiol., Cell Physiol. pmid:11788348
Algeciras-Schimnich A et al. Molecular ordering of the initial signaling events of CD95. 2002 Mol. Cell. Biol. pmid:11739735
Mueller A et al. Pathways for internalization and recycling of the chemokine receptor CCR5. 2002 Blood pmid:11806977
Schraw W et al. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. 2002 J. Biol. Chem. pmid:12121984
Iwabuchi K and Nagaoka I Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. 2002 Blood pmid:12149231
Selinka HC et al. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. 2002 Virology pmid:12202231
Anil S and Samaranayake LP Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole. 2002 Oral Dis pmid:12206401
Freed EO Virology. Rafting with Ebola. 2002 Science pmid:11951027
Barrero AF et al. Sterols in erg mutants of Phycomyces: metabolic pathways and physiological effects. 2002 Steroids pmid:11958798
Marella M et al. Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. 2002 J. Biol. Chem. pmid:11994310
Wasylnka JA and Moore MM Uptake of Aspergillus fumigatus Conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein. 2002 Infect. Immun. pmid:12011010
Gubler F et al. Gibberellin signaling in barley aleurone cells. Control of SLN1 and GAMYB expression. 2002 Plant Physiol. pmid:12011350
Dannaoui E et al. In vitro susceptibilities of Zygomycota to polyenes. 2002 J. Antimicrob. Chemother. pmid:12003966
Gøtzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2002 Cochrane Database Syst Rev pmid:12076436
Zhang L et al. Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. 2002 J. Antimicrob. Chemother. pmid:12039882
Casalaz D Fluconazole prophylaxis against fungal infection in preterm infants. 2002 N. Engl. J. Med. pmid:12066811
Holý R and Pozivil J Batch control system project for a pharmaceutical plant. 2002 ISA Trans pmid:12071257
Triantafilou M et al. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. 2002 J. Cell. Sci. pmid:12045230
Dubernet S et al. Nystatin and osmotica as chemical enhancers of the phenotypic adaptation to freeze-thaw stress in Geotrichum candidum ATCC 204307. 2002 Int. J. Food Microbiol. pmid:12051478
Varela D et al. Effect of an N-terminus deletion on voltage-dependent gating of the ClC-2 chloride channel. 2002 J. Physiol. (Lond.) pmid:12381811
Volpon L and Lancelin JM Solution NMR structure of five representative glycosylated polyene macrolide antibiotics with a sterol-dependent antifungal activity. 2002 Eur. J. Biochem. pmid:12230565
Marrazzo J Vulvovaginal candidiasis. 2002 BMJ pmid:12228137
Ruiz-Sánchez D et al. Intestinal candidiasis. A clinical report and comments about this opportunistic pathology. 2002 Mycopathologia pmid:12715941
Robeck TR and Dalton LM Saksenaea vasiformis and Apophysomyces elegans zygomycotic infections in bottlenose dolphins (Tursiops truncatus), a killer whale (Orcinus orca), and pacific white-sided dolphins (Lagenorhynchus obliquidens). 2002 J. Zoo Wildl. Med. pmid:12564534
Uchiro H et al. The first synthesis and antifungal activities of 9-methoxystrobilurin-type beta-substituted beta-methoxyacrylate. 2002 Bioorg. Med. Chem. Lett. pmid:12270154
Goins RA et al. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. 2002 Pediatr. Infect. Dis. J. pmid:12506950
Marley PD et al. How does histamine evoke catecholamine secretion from bovine chromaffin cells? 2002 Ann. N. Y. Acad. Sci. pmid:12438107
Gøtzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2002 Cochrane Database Syst Rev pmid:12519566
Pérez Prim FJ and Vila I [Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis]. 2002 Aten Primaria pmid:12525346
Llabot JM et al. Double-layered mucoadhesive tablets containing nystatin. 2002 AAPS PharmSciTech pmid:12916937
Moribe K and Maruyama K Pharmaceutical design of the liposomal antimicrobial agents for infectious disease. 2002 Curr. Pharm. Des. pmid:12069381
Stuart AD et al. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. 2002 J. Virol. pmid:12186914